It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 2004.
2004 | Jaipur, Rajasthan, India | ActiveBiogenetic Drugs Private Limited, a active private limited company, was established on 23 January 2004 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232RJ2004PTC018909. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.94 Cr.
It upholds a compliant status. Its leadership includes Raj Kumar (Additional Director), Vibhor Goyal (Director), Mukut Bihari Goyal (Director). Past directors included Vibhor Goyal, Mukta Goyal, Updesh Yadav. It holds ₹36.25 Cr open charges and ₹26.71 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 66, Mathur Vaish Nagartonk Road,, Jaipur, Rajasthan.
U24232RJ2004PTC018909
018909
23 January 2004
₹3.00 Cr
₹2.94 Cr
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Biogenetic Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Kumar | Additional Director | 27 Feb 2025 | Current |
| Vibhor Goyal | Director | 21 Jan 2012 | Current |
| Mukut Bihari Goyal | Director | 23 Jan 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 15 Mar 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biogenetic Drugs Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Biogenetic Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹362,500,000.00
₹267,148,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2023 | State Bank Of India | ₹7.25 Cr | Open |
| 30 Oct 2017 | State Bank Of India | ₹29.00 Cr | Open |
| 14 Mar 2017 | Sidbi | ₹3.10 Cr | Satisfied |
| 11 Nov 2011 | Small Industries Development Bank Of India | ₹3.50 M | Satisfied |
| 21 Apr 2011 | Union Bank Of India | ₹1.10 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Biogenetic Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biogenetic Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biogenetic Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Raj Kumar was appointed as a Additional Director was appointed as a Additional Director on 27 Feb 2025 & has been associated with this company since 9 months 5 days . was documented.
Progress on A charge with State Bank Of India of Rs. 29.00 Cr registered on 30 Oct 2017 with Charge ID 100149810 was modified on 15 Feb 2025. was documented.
Progress on Biogenetic Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Biogenetic Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was completed.
A charge with State Bank Of India amounted to Rs. 7.25 Cr with Charge ID 100721936 was registered on 23 May 2023. was recorded as a recent event.
Progress on A charge registered on 21 Apr 2011 via Charge ID 10285226 with Union Bank Of India was fully satisfied on 15 Oct 2018. was documented.
The CIN of Biogenetic Drugs Private Limited is U24232RJ2004PTC018909.
Biogenetic Drugs Private Limited is headquartered at 66, Mathur Vaish Nagartonk Road,, Jaipur, Rajasthan.
Biogenetic Drugs Private Limited was incorporated on 23 January 2004.
The current directors of Biogenetic Drugs Private Limited are
The primary industry of Biogenetic Drugs Private Limited is Manufacturing.
Biogenetic Drugs Private Limited is unlisted.
The authorized capital of Biogenetic Drugs Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.94 Cr.
The compliance status of Biogenetic Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX